According to MarketsandMarkets™, the Multiomics Market is projected to reach USD 5.70 billion by 2031 from USD 3.18 billion ...

PacBio (NASDAQ: PACB), developer of the world’s most advanced sequencing technologies, today announced the upcoming availability of SPRQ-Nx chemistry and an accompanying software update for its Vega ...

This is a valuable study addressing a debated question in brain repair research by testing whether NeuroD1 can convert brain immune cells into nerve cells using a virus-free genetic approach and live ...

China's Cyberspace Administration launched a formal national security review of Palo Alto Networks products sold in China on Thursday, initiating a legal process that previously produced an ...

Vivodyne’s platform provides the foundation of the first world model of human biology. Previously, the controlled experiments ...

Samsung humanoid robot news from Korean tech press reveals a secret in-house program, separate from the RX division and ...

Q. What are Synopsys’ main product lines and offerings? A. Synopsys operates across three major product lines. The first is electronic design automation (EDA), which supports the complete chip design ...

Technology stocks were surging early Tuesday but the beaten-down software sector was only enduring more pain as the artificial-intelligence trade sparked back into life. Chip stocks, including Intel, ...

Maiden Fletcher Ore Reserve of 13.5Mt at 2.6g/t Au for 1.1Moz establishes a substantial new mineable inventory at Beta Hunt - supported by completed mine planning, commercial evaluation and a ...

While EDA incumbents like Cadence and Synopsys integrate AI, three startups are vying for market adoption, which could also portend a new pricing model ...

Ansys deal could lift chip lifecycle monetization. FY2026 revenue growth is largely acquisition-driven. See more here.